Metraipolis › archive › dc_6585320d423f
Effective vemurafenib monotherapy for refractory Langerhans cell histiocytosis with sustained results post-withdrawal for over two years: a case report — Europe PMC PMID:41142607
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41142607
- DOI
- 10.3389/fonc.2025.1688802
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T11:00:58.048Z
- SHA-256 of the archived text
f67990cc09c5296c487533d5840c0159c17ea07c2e9a5292df0f68bd5a89ed0a- Stable URL of this page
https://metraipolis.com/documento/dc_6585320d423f
How to cite
Effective vemurafenib monotherapy for refractory Langerhans cell histiocytosis with sustained results post-withdrawal for over two years: a case report — Europe PMC PMID:41142607 — Europe PMC (en), https://europepmc.org/article/MED/41142607 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6585320d423f (Metraipolis archive dc_6585320d423f, sha256 f67990cc09c5296c487533d5840c0159c17ea07c2e9a5292df0f68bd5a89ed0a)
BibTeX
@misc{dc6585320d423f,
title = {Effective vemurafenib monotherapy for refractory Langerhans cell histiocytosis with sustained results post-withdrawal for over two years: a case report — Europe PMC PMID:41142607},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41142607},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6585320d423f; sha256 f67990cc09c5296c487533d5840c0159c17ea07c2e9a5292df0f68bd5a89ed0a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41142607. Agents can read the archived copy with the MCP tool read_document.